Rx · PZN 12418590, 12418609, 05004451
ATRIPLA 600 mg/200 mg/245 mg film-coated tablets
German trade nameATRIPLA 600 mg-200 mg-245 mg Filmtabletten
According to the data available to us: no longer marketed
No observed availability
0.0out of 10
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for ATRIPLA 600 mg/200 mg/245 mg film-coated tablets.
Review purchasing termsATRIPLA 600 mg/200 mg/245 mg film-coated tablets contains the active ingredient Emtricitabine, tenofovir disoproxil and efavirenz (German Emtricitabin, Tenofovirdisoproxil und Efavirenz) and comes as Film-coated tablets. 3 pack sizes of this product are recorded. All packs reach a pharma availability index of 0.0 out of 10 over the past 30 days. According to our records, none of the recorded packs is currently marketed on a regular basis – sources of supply can be checked on request.
Pack sizes · 3 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 12418590 | 0.0 | 0.0 | ~ €917 |
| 12418609 | 0.0 | 0.0 | ~ €2,793 |
| 05004451 | 0.0 | 0.0 | ~ €1,729 |
According to the data available to us, ATRIPLA 600 mg/200 mg/245 mg film-coated tablets is no longer regularly marketed. We help you identify successor products, remaining stock and import routes.
Request a source of supply